EcoDrugPlus

Anti-Apoptotic Protein Nr13

Ensembl ID : ENSONIG00000035360
Gene Symbol: LOC100699619
3 Cross references
128 Possible Orthologues:

Apelin Receptor B

Ensembl ID : ENSONIG00000034057
Gene Symbol: LOC100690011
3 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSONIG00000039660
Gene Symbol: APH1A
3 Cross references
190 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSONIG00000018377
Gene Symbol: ALOX5
4 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSONIG00000003863
Gene Symbol: LOC100698983
4 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSONIG00000012702
Gene Symbol: ALOX5AP
4 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSONIG00000008870
Gene Symbol: AVPR1A
4 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSONIG00000017980
Gene Symbol: AVPR1A
4 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSONIG00000032219
Gene Symbol: AVPR2
4 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSONIG00000016572
Gene Symbol: AVPR2
1 Cross references
148 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2

Ensembl ID : ENSONIG00000012850
Gene Symbol: LOC100699899
2 Cross references
185 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSONIG00000041999
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).